technetium tc 99m hydroxymethylene diphosphonate has been researched along with meglumine in 1 studies
| Studies (technetium tc 99m hydroxymethylene diphosphonate) | Trials (technetium tc 99m hydroxymethylene diphosphonate) | Recent Studies (post-2010) (technetium tc 99m hydroxymethylene diphosphonate) | Studies (meglumine) | Trials (meglumine) | Recent Studies (post-2010) (meglumine) |
|---|---|---|---|---|---|
| 618 | 35 | 87 | 4,168 | 413 | 1,399 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benhaiem, N; Damy, T; Deux, JF; Itti, E; Kobeiter, H; Legou, F; Luciani, A; Planté-Bordeneuve, V; Rahmouni, A; Rappeneau, S; Rosso, J; Tacher, V | 1 |
1 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and meglumine
| Article | Year |
|---|---|
Usefulness of T2 ratio in the diagnosis and prognosis of cardiac amyloidosis using cardiac MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Amyloidosis; Case-Control Studies; Contrast Media; Female; Heart Diseases; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging, Cine; Male; Meglumine; Middle Aged; Myocardial Perfusion Imaging; Organometallic Compounds; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Medronate | 2017 |